By reducing collagen accumulation, pulmonary fibrosis can be effectively improved through TGF-β1 and NLRP3 pathways and decreasing the levels of inflammation factors (Nie et al., 2017; Tian et al., 2017). The gene discussed is TGFB1; the disease is pulmonary fibrosis.